Suzanne Oparil, MD, Co-chair
Professor of Medicine, Physiology and Biophysics
Director of the Vascular Biology and Hypertension Program of the Division of
Department of Medicine
University of Alabama at Birmingham
Suzanne Oparil, MD received her medical degree at Columbia University College of Physicians and Surgeons in New York, and completed her medical residency at Columbia Presbyterian Hospital and cardiology fellowship at Massachusetts General Hospital. Dr. Oparil has made many significant contributions to vascular biology and hypertension research. She serves on various editorial boards and has an extensive publication record, with more than 700 journal articles, books, or book chapters on clinical cardiology, atherosclerosis, heart failure, vascular biology, and hypertension. Dr. Oparil has been president of the American Heart Association, the American Society of Hypertension, and the American Federation for Medical Research.
Roland Schmieder, MD, Co-chair
Professor of Internal Medicine, Nephrology, and Hypertension
Head of the Clinical Research Center of Hypertension and Vascular Medicine
Department of Nephrology and Hypertension of the University Hospital
Roland E. Schmieder, MD directs the Institute of Preventative Medicine at the University Erlangen-Nuremberg and at the Community Hospital Nuremberg, Germany. Professor Schmieder has extensive experience in the execution of human clinical trials, reflected by more than 300 publications in peer-reviewed journals. His research interests include nephrology, hypertension, non-invasive cardiology, and vascular medicine. He is an advisor and steering board member of several European and international multicenter studies. A notable member and advisor to numerous societies and committees, Prof. Schmieder is a fellow of the American College of Physicians, the American College of Cardiology, and the European Society of Cardiology.
Brent M. Egan, MD
Professor of Medicine and Pharmacology
Medical University of South Carolina
Charleston, South Carolina
Brent M. Egan, MD received his medical degree and training in medicine and hypertension at the University of Michigan. His clinical and basic research examines mechanisms of cardiovascular risk in obesity and suggests that fatty acids participate in the pathophysiology of the metabolic syndrome through oxidative stress-sensitive pathways. His research is currently examining the effects of the DASH Eating Plan on oxidative stress in metabolic syndrome patients. Dr. Egan is active in the American Society of Hypertension (ASH) where he currently serves as vice president.
Guido Grassi, MD
Professor, Institute of Clinical Medicine
Department of Clinical Medicine, Prevention and Applied Biotechnologies
University of Milan
Guido Grassi, MD is director of the post-graduate School of Internal Medicine at the University of Milano-Bicocca. Dr. Grassi’s research areas include the pathophysiology, clinical pharmacology and treatment of hypertension, obesity and metabolic syndrome, cardiac arrhythmias, and heart failure. He has published more than 350 original papers and reviews in major scientific international journals and is the executive editor of the Journal of Hypertension. Dr. Grassi is a member of the International Society of Hypertension, European Society of Hypertension and High Blood Pressure Council. He previously served as treasurer and secretary of the Italian Society of Hypertension.
Sverre Erik Kjeldsen MD
Professor and Chief Physician/Senior Consultant, Department of Cardiology
University of Oslo
Sverre E. Kjeldsen, MD received his medical degree and PhD from University of Oslo. His research areas of interest include pathophysiology, epidemiology and the treatment of human hypertension. He has published nearly 300 peer-reviewed original articles and has served as an executive or steering committee member of several large clinical outcome trials in hypertension, including NORDIL, INSIGHT, LIFE, VALUE, ASCOT, ACCOMPLISH, SCAST, and HOT. Dr. Kjeldsen served as president of the European Society of Hypertension from 2005-2007 and he is a fellow of the American Heart Association and the Council for High Blood Pressure Research. He has since mid 1980s been adjunct with Divisions of Hypertension and Cardiovascular Medicine at University of Michigan, Ann Arbor, Michigan.
Michael A. Weber, MD
Professor of Medicine
SUNY Downstate Medical Center
Brooklyn, New York
Michael A. Weber, MD received his medical degree from the University of Sydney in Sydney, Australia. An expert in the field of hypertension and preventive cardiology, Dr. Weber published numerous research articles and has authored or edited 16 books. He has made significant contributions to research of patients at high risk of cardiovascular events or strokes, and is also involved in clinical trials of metabolic disorders such as diabetes and kidney disease. Dr. Weber is one of the founders of The American Society of Hypertension and served as its president from 1998 to 2000.
Jackson T. Wright, Jr., MD, PhD, FACP
Professor of Medicine and Program Director
General Clinical Research Centre
Case Western Reserve University
Director, Clinical Hypertension Program
University Hospitals Case Medical Center
Jackson T. Wright, Jr., MD, PhD received his MD and PhD (pharmacology) from the University of Pittsburgh and internal medicine residence at the University of Michigan. An experienced clinical investigator, he has more than 240 publications. His research accomplishments include having a major or leadership role in most of the major clinical outcome trials conducted in black populations over the past 2 decades. Among these, he first authored the primary results paper for the NIH-sponsored African American Study of Kidney Disease in Hypertensives Trial and was Vice Chair of the Antihypertensive and Lipid Lowering to prevent Heart Attack Trial. Dr. Wright has served on the NIH panel that drafted the US national guidelines for treating high blood pressure and currently serves on the panel drafting the update to that document.